Efficacy and Treatment Persistence of First-line Natalizumab vs. Interferon β or Glatiramer Acetate in relapsing MS.

H Butzkueven, T Spelman, T Kalincik, V Jokubaitis, A Zhang, F Pellegrini, H Wiendl, S Belachew, R Hyde, F Verheul, A Lugaresi, E Havrdova, D Horakova, P Grammond, P Duquette, A Prat, G Iuliano, M Terzi, G Izquierdo, R Hupperts Show all